Publishing: Informa Healthcare

The Journal of Drug Assessment is a quarterly publication, available on subscription, covering all aspects of drug evaluation. A section entitled \'Models of Drug Assessment\' presents reviews and analyses of various models used by organisations faced with having to prioritise drug choice in a given therapeutic area. Reviews and clinical opinion papers are also published. A variety of factors – increasing health needs, cost containment measures, pressure to provide health services efficiently – have catapulted the areas of clinical research, medical economics and outcomes research into the front line of issues affecting healthcare. Those who provide and pay for healthcare services, along with the pharmaceutical industry, must now be fully informed about the consequences of choosing a particular therapy. Efficacy and safety are no longer the only benchmarks against which to evaluate novel therapeutics: the scope has now broadened to include social and economic issues as well. Indeed, failure to consider the wider implications of a product may limit its availability and market success. It is vital that healthcare professionals have access to high quality research into all aspects of new and established therapeutics – which is why a subscription to the Journal of Drug Assessment makes sense.

download